Drug Approval | May 31, 2021
Cadila Healthcare’s margin supported by lower R&D : ICICI Securities
India formulations business grew 14.7% YoY with recovery in industry growth from COVID-19 impact
India formulations business grew 14.7% YoY with recovery in industry growth from COVID-19 impact
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
Analysts expect modest revenue growth but pressure on profitability in the March quarter
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
The launch coincides with IBS Awareness Month in April
PMDA is regarded among the most stringent regulatory bodies globally
The innovation is particularly suited for bone and cartilage repair
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Subscribe To Our Newsletter & Stay Updated
